Advancing Metal-Based Anticancer Drugs with ICP-MS and Imaging MS Techniques
August 09, 2021
Metallomics approaches based on mass spectrometry have become increasingly important in the support of developing metal-based anticancer drugs. This area is a key focus for Gunda Koellensperger and her colleagues at the University of Vienna (Austria) and they recently published an article discussing this state-of-the-art instrumentation, as well as highlighting recent analytical advances, focusing especially on the latest developments in inductively coupled plasma-–mass spectrometry (ICP-MS).